feed,title,long_url,short_url
Benzinga,Ionis-Biogen Partnered Amyotrophic Lateral Sclerosis Trial Disappoints,https://benzinga.com/general/biotech/22/03/26321467/ionis-biogen-partnered-amyotrophic-lateral-sclerosis-trial-disappoints,https://bit.ly/3uGmHxM
Benzinga,5 Short Squeeze Candidates To Watch: Indonesia Energy Gives Way To New Oil Stocks,https://benzinga.com/news/22/03/26321095/5-short-squeeze-candidates-to-watch-indonesia-energy-gives-way-to-new-oil-stocks,https://bit.ly/35igTSd
Benzinga,"Incyte's Ruxolitinib Shows Further Improvement In Facial, Total Body Re-pigmentation At 52 Weeks In Skin Disorder",https://benzinga.com/general/biotech/22/03/26318681/incytes-ruxolitinib-shows-further-improvement-in-facial-total-body-re-pigmentation-at-52-weeks-in,https://bit.ly/3qIo7Gx
